These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

674 related articles for article (PubMed ID: 24647021)

  • 61. [In vitro susceptibility of methicillin-resistant Staphylococcus aureus isolates to vancomycin, teicoplanin, linezolide and daptomycin].
    Celikbilek N; Ozdem B; Gürelik FC; Güvenman S; Güner HR; Açıkgöz ZC
    Mikrobiyol Bul; 2011 Jul; 45(3):512-8. PubMed ID: 21935784
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Use of daptomycin to treat infections with methicillin-resistant Staphylococcus aureus isolates having vancomycin minimum inhibitory concentrations of 1.5 to 2 μg/mL.
    McDaneld PM; Spooner LM; Mohr JF; Belliveau PP
    Ann Pharmacother; 2013 Dec; 47(12):1654-65. PubMed ID: 24259618
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Impact of Vancomycin MIC on Treatment Outcomes in Invasive Staphylococcus aureus Infections.
    Song KH; Kim M; Kim CJ; Cho JE; Choi YJ; Park JS; Ahn S; Jang HC; Park KH; Jung SI; Yoon N; Kim DM; Hwang JH; Lee CS; Lee JH; Kwak YG; Kim ES; Park SY; Park Y; Lee KS; Lee YS; Kim HB
    Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 27956430
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Synergistic activity of ceftobiprole and vancomycin in a rat model of infective endocarditis caused by methicillin-resistant and glycopeptide-intermediate Staphylococcus aureus.
    Fernandez J; Abbanat D; Shang W; He W; Amsler K; Hastings J; Queenan AM; Melton JL; Barron AM; Flamm RK; Lynch AS
    Antimicrob Agents Chemother; 2012 Mar; 56(3):1476-84. PubMed ID: 22232278
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Right endocarditis caused by Staphylococcus aureus in parenteral drug addicts: evaluation of a combined therapeutic scheme for 2 weeks versus conventional treatment].
    Espinosa FJ; Valdés M; Martín-Luengo F; Arribas JP; Albaladejo J; Pérez-Gracia A; García-Henarejos JA; Martínez-Madrid O; García-Alberola A
    Enferm Infecc Microbiol Clin; 1993 May; 11(5):235-40. PubMed ID: 8324018
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Activities of antistaphylococcal antibiotics towards the extracellular and intraphagocytic forms of Staphylococcus aureus isolates from a patient with persistent bacteraemia and endocarditis.
    Lemaire S; Kosowska-Shick K; Julian K; Tulkens PM; Van Bambeke F; Appelbaum PC
    Clin Microbiol Infect; 2008 Aug; 14(8):766-77. PubMed ID: 18727801
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Assessment of invitrosynergy of daptomycin or vancomycin plus ceftaroline for daptomycin non-susceptible Staphylococcus aureus.
    Hutton MA; Sundaram A; Perri MB; Zervos MJ; Herc ES
    Diagn Microbiol Infect Dis; 2020 Nov; 98(3):115126. PubMed ID: 32861155
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Impact of area under the concentration-time curve to minimum inhibitory concentration ratio on vancomycin treatment outcomes in methicillin-resistant Staphylococcus aureus bacteraemia.
    Song KH; Kim HB; Kim HS; Lee MJ; Jung Y; Kim G; Hwang JH; Kim NH; Kim M; Kim CJ; Choe PG; Chung JY; Park WB; Kim ES; Park KU; Kim NJ; Kim EC; Oh MD
    Int J Antimicrob Agents; 2015 Dec; 46(6):689-95. PubMed ID: 26555059
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Teicoplanin versus cloxacillin, cloxacillin-gentamycin and vancomycin in the treatment of experimental endocarditis caused by methicillin-sensitive Staphylococcus aureus].
    Apellaniz G; Valdés M; Pérez R; Martín-Luengo F; García A; Soria F; Gómez J
    Enferm Infecc Microbiol Clin; 1991 Apr; 9(4):208-10. PubMed ID: 1830757
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Pharmacodynamic comparison of different antimicrobial regimens against Staphylococcus aureus bloodstream infections with elevated vancomycin minimum inhibitory concentration.
    da Costa TM; Cuba GT; Morgado PGM; Nicolau DP; Nouér SA; Dos Santos KRN; Kiffer CRV
    BMC Infect Dis; 2020 Jan; 20(1):74. PubMed ID: 31973753
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Comparative efficacy of amoxicillin-clavulanate, cloxacillin, and vancomycin against methicillin-sensitive and methicillin-resistant Staphylococcus aureus endocarditis in rats.
    Cantoni L; Wenger A; Glauser MP; Bille J
    J Infect Dis; 1989 May; 159(5):989-93. PubMed ID: 2708846
    [No Abstract]   [Full Text] [Related]  

  • 72. Prior vancomycin use is a risk factor for reduced vancomycin susceptibility in methicillin-susceptible but not methicillin-resistant Staphylococcus aureus bacteremia.
    Mascitti KB; Edelstein PH; Fishman NO; Morales KH; Baltus AJ; Lautenbach E
    Infect Control Hosp Epidemiol; 2012 Feb; 33(2):160-6. PubMed ID: 22227985
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Daptomycin antimicrobial activity tested against methicillin-resistant staphylococci and vancomycin-resistant enterococci isolated in European medical centers (2005).
    Sader HS; Watters AA; Fritsche TR; Jones RN
    BMC Infect Dis; 2007 Apr; 7():29. PubMed ID: 17442104
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The first pediatric case of Staphylococcus aureus with heterogenous resistant to vancomycin endocarditis in Thailand.
    Phongsamart W; Srifeungfung S; Tiensasitorn C; Vanprapar N; Chearskul S; Chokephaibulkit K
    J Med Assoc Thai; 2005 Nov; 88 Suppl 8():S264-8. PubMed ID: 16856450
    [TBL] [Abstract][Full Text] [Related]  

  • 75. High vancomycin MIC and complicated methicillin-susceptible Staphylococcus aureus bacteremia.
    Aguado JM; San-Juan R; Lalueza A; Sanz F; Rodríguez-Otero J; Gómez-Gonzalez C; Chaves F
    Emerg Infect Dis; 2011 Jun; 17(6):1099-102. PubMed ID: 21749780
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Association between vancomycin day 1 exposure profile and outcomes among patients with methicillin-resistant Staphylococcus aureus infective endocarditis.
    Casapao AM; Lodise TP; Davis SL; Claeys KC; Kullar R; Levine DP; Rybak MJ
    Antimicrob Agents Chemother; 2015; 59(6):2978-85. PubMed ID: 25753631
    [TBL] [Abstract][Full Text] [Related]  

  • 77. In vitro activity of ceftobiprole, daptomycin, linezolid, and vancomycin against methicillin-resistant staphylococci associated with endocarditis and bone and joint infection.
    Rouse MS; Steckelberg JM; Patel R
    Diagn Microbiol Infect Dis; 2007 Jul; 58(3):363-5. PubMed ID: 17449212
    [TBL] [Abstract][Full Text] [Related]  

  • 78. New agents for Staphylococcus aureus endocarditis.
    Drees M; Boucher H
    Curr Opin Infect Dis; 2006 Dec; 19(6):544-50. PubMed ID: 17075329
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Antistaphylococcal β-Lactams versus Vancomycin for Treatment of Infective Endocarditis Due to Methicillin-Susceptible Coagulase-Negative Staphylococci: a Prospective Cohort Study from the International Collaboration on Endocarditis.
    Carugati M; Petti CA; Arnold C; Miro JM; Pericàs JM; Garcia de la Maria C; Kanafani Z; Durante-Mangoni E; Baddley J; Wray D; Klein JL; Delahaye F; Fernandez-Hidalgo N; Hannan MM; Murdoch D; Bayer A; Chu VH
    Antimicrob Agents Chemother; 2016 Oct; 60(10):6341-9. PubMed ID: 27527083
    [TBL] [Abstract][Full Text] [Related]  

  • 80. High MICs for Vancomycin and Daptomycin and Complicated Catheter-Related Bloodstream Infections with Methicillin-Sensitive Staphylococcus aureus.
    San-Juan R; Viedma E; Chaves F; Lalueza A; Fortún J; Loza E; Pujol M; Ardanuy C; Morales I; de Cueto M; Resino-Foz E; Morales-Cartagena A; Rico A; Romero MP; Orellana MÁ; López-Medrano F; Fernández-Ruiz M; Aguado JM
    Emerg Infect Dis; 2016 Jun; 22(6):1057-66. PubMed ID: 27192097
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 34.